HeartWare names Peter F. McAree as CFO

Monday, July 9, 2012 04:48 PM

HeartWare International, a developer of less invasive, miniaturized circulatory support technologies for treatment of advanced heart failure, has appointed Peter F. McAree as senior vice president, CFO and Treasurer

McAree brings more than 25 years of financial management and public accounting experience to HeartWare International. He most recently served as senior vice president and CFO at Caliper Life Sciences, prior to the company's acquisition by PerkinElmer in November, 2011. McAree also served as CFO of Zymark prior to the company's merger with Caliper in 2003. 

Outside the pharmaceutical and medical device industry, McAree has served in many financial leadership positions, including Arthur Andersen and Enterprise Group.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs